Oral antihistamine/decongestant treatment compared with intranasal corticosteroids in seasonal allergic rhinitis

Clinical and Experimental Allergy

Volumn 25, Issue 1, 1995, Pages 60-65

  Negrini, A C ^a   Troise, C ^a   Voltolini, S ^a   Horak, F ^a   Bachert, C ^a   Janssen, M ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; BECLOMETASONE; CORTICOSTEROID; DECONGESTIVE AGENT; NOSE SPRAY; PSEUDOEPHEDRINE;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0028911972     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1995.tb01003.x     Document Type: Article

References (15)

1. 1 Weeke ER. Epidemiology of hay fever and perennial allergic rhinitis. Monogr Allergy 1987 ; 21: 1–20.
2. 2 White MV. The role of histamine in allergic diseases. J Allergy Clin Immunol 1990 ; 86: 599–605.
3. 3 Badhwar AK, Druce HM. Allergic rhinitis. Clin Allergy 1992 ; 76: 789–803.
4. 4 Busse W. New directions and dimensions in the treatment of allergic rhinitis. J. Allergy Clin Immunol 1988 ; 82: 890–900.
5. 5 Delafuente JC, Davis TA, Davis JA. Pharmacotherapy of allergic rhinitis. Clin Pharmacol 1989 ; 8: 474–85.
6. 6 Fox, R, Lockey R, Altenburger K et al. Clinical evaluation of the safety and efficacy of astcmizole/pseudocphedrine combination in the treatment of fall hayfever. J Allergy Clin Immunol 1990 ; 85 (Suppl): 243.
7. 7 Grant JA, Lopez M, Munk Z, Woehler T. Comparison of once‐daily astemizole‐pseudoephedrine combination with each component and a placebo in seasonal allergic rhinitis. Ann Allergy 1990 ; 64: 91.
8. 8 Hampel F, van Bavel J, Paull B et al. Double‐blind randomized multicentre trial of Hismanal‐D in seasonal allergic rhinitis. J Allergy Clin Immunol 1990 ; 85 (Suppl): 237.
9. 9 Grant JA, Fox R, Hampel F, Gross G. Meta‐analysis of Hismanal‐D clinical trials in seasonal allergic rhinitis. Allergy 1992 ; 47 (Suppl): 242.
10. 10 Brogden RN, Heel RC, Speight TM, Avery GS. Beclo‐methasone dipropionate: a reappraisal of its pharmacody‐namic properties and therapeutic efficacy after a decade of use in asthma and rhinitis. Drugs 1984 ; 28: 99–126.
11. 11 Munch EP, Søborg M, Nørreslet TJ, Mygind N. A comparative study of dexchlorpheniramine maleale sustained release tablets and budesonide nasal spray in seasonal allergic rhinitis. Allergy 1983 ; 38: 517–24.
12. 12 Beswick KBJ, Kenyon GS, Cherry JR. A comparative study of beclomethasone dipropionate aqueous nasal spray with terfenadine tablets in seasonal allergic rhinitis. Curr Med Res Opin 1985: 9: 560–7.
13. 13 Wood SF. Oral antihistamine or nasal steroid in hay fever: a double‐blind, double‐dummy, comparative study of once daily oral astemizole vs twice daily nasal beclomethasone dipropionate. Clin Allergy 1986 ; 16: 195–201.
14. 14 Idzikowski C, Emanuel M, James R. Nicholls A. The effect of astemizole, terfenadine and pseudoephedrine combinations on sleep in healthy volunteers. Allergy 1992 ; 47 (Suppl): 100.
15. 15 Janssens MML, Lins RL. Astemizole‐D causes less sleep impairment than loratadine‐D, Eur J Clin Pharmacol, in press.